-
- Kim B. Jackson
- MED-EL Corporation, North America, Research Tringle Park, 2222 East Highway 54, Beta Building, Suite 180, Durham, NC 27713
-
- Gerhard Mark
- MED-EL Medical Electronics, Innsbruck, Austria
-
- Jan Helms
- University Clinic Wuerzburg, Germany
-
- Joachim Mueller
- University Clinic Wuerzburg, Germany
-
- Robert Behr
- University of Marburg, Klinikum Fulda, Germany
抄録
<jats:p>Neurofibromastosis type II (NF2) is a condition that may result in bilateral acoustic neuromas. The tumors and their removal may cause profound bilateral deafness. Because the auditory nerve is compromised, people with NF2 are unable to receive a cochlear implant to restore a sensation of hearing. Electrical stimulation of the auditory pathway can provide hearing in such people. This is possible by means of an auditory brainstem implant (ABI). This article focuses on the MED-EL highrate multichannel ABI system. The system consists of the implanted and external components. Appropriate placement of the ABI is dependent on electrical auditory brainstem response testing performed intra-operatively. Data on a group of European patients implanted with the MED-EL ABI are presented. Results are promising and include some open-set speech ability.</jats:p>
収録刊行物
-
- American Journal of Audiology
-
American Journal of Audiology 11 (2), 128-133, 2002-12
American Speech Language Hearing Association
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1364233269733218688
-
- NII論文ID
- 30021587662
-
- ISSN
- 15589137
- 10590889
-
- データソース種別
-
- Crossref
- CiNii Articles